Neuroimaging findings in alcohol-related encephalopathies

American Journal of Roentgenology

Volumn 195, Issue 6, 2010, Pages 1378-1384

  Zuccoli, Giulio ^a   Siddiqui, Nasir ^a   Cravo, Isabel ^b   Bailey, Ariel ^a   Gallucci, Massimo ^c   Harper, Clive G ^d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b HOSPITAL FERNANDO FONSECA   (Portugal)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alcohol abuse; Alcohol withdrawal delirium; Central pontine myelinolysis; Extrapontine myelinolysis; Hepatic encephalopathy; Marchiafava Bignami disease; Nervous system; Wernicke encephalopathy

Indexed keywords

ALCOHOL RELATED ENCEPHALOPATHY; ALCOHOL WITHDRAWAL; BRAIN DISEASE; CLINICAL FEATURE; DEMYELINATION; DIAGNOSTIC IMAGING; DNA DAMAGE; HEPATIC ENCEPHALOPATHY; HUMAN; MARCHIAFAVA BIGNAMI DISEASE; NEUROIMAGING; OSMOTIC DEMYELINATION SYNDROME; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SERUM OSMOLARITY; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; AVITAMINOSIS; BRAIN; DIAGNOSTIC IMAGING; DNA DAMAGE; HUMANS; OXIDATIVE STRESS; WERNICKE ENCEPHALOPATHY;

EID: 78649741355     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.09.4130     Document Type: Review

References (72)

1. Decker MJ, Isaacman DJ. A common cause of altered mental status occurring at an uncommon age. Pediatr Emerg Care 2000; 16:94-96
2. Michowitz Y, Copel L, Shiloach E, Litovchik I, Rapoport MJ. Non-alcoholic Wernicke's encephalopathy: unusual clinical findings. Eur J Intern Med 2005; 16:443-444
3. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007; 6:442-455
4. Vasconcelos MM, Silva KP, Vidal G, Silva AF, Domingues RC, Berditchevsky CR. Early diagnosis of pediatric Wernicke's encephalopathy. Pediatr Neurol 1999; 20:289-294
5. Leevy CM. Thiamine deficiency and alcoholism. Ann N Y Acad Sci 1982; 378:316-326
6. Butterworth RF, Kril JJ, Harper CG. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res 1993; 17:1084-1088
7. Kril JJ. Neuropathology of thiamine deficiency disorders. Metab Brain Dis 1996; 11:9-17
8. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986; 49:341-3459.
9. Zuccoli G, Santa Cruz D, Bertolini M, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR 2009; 30:171-176
10. Zuccoli G, Siddiqui N, Bailey A, Bartoletti SC. Neuroimaging findings in pediatric Wernicke encephalopathy: a review. Neuroradiology 2010; 52:523-529
11. Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, Urbano-Marquez A. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR 1998; 171:1131-1137
12. Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR 2009; 192:501-508
13. Zuccoli G, Gallucci M, Capellades J, et al. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR 2007; 28:1328-1331
14. Rugilo CA, Uribe Roca MC, Zurru MC, Capizzano AA, Pontello GA, Gatto EM. Proton MR spectroscopy in Wernicke encephalopathy. AJNR 2003; 24:952-955
15. Victor M. Persistent altered mentation due to ethanol. Neurol Clin 1993; 11:639-661
16. Marjama J, Yoshino MT, Reese C. Marchiafava-Bignami disease: premortem diagnosis of an acute case utilizing magnetic resonance imaging. J Neuroimaging 1994; 4:106-109
17. Gambini A, Falini A, Moiola L, Comi G, Scotti G. Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. AJNR 2003; 24:249-253
18. Toelle SP, Huisman TA, Martin E, Boltshauser E. Marchiafava-Bignami-like injury of the corpus callosum in an infant. Neuropediatrics 2005; 36:328-331
19. Ihn YK, Hwang SS, Park YH. Acute Marchiafava-Bignami disease: diffusion-weighted MRI in cortical and callosal involvement. Yonsei Med J 2007; 48:321-324
20. Spampinato MV, Castillo M, Rojas R, Palacios E, Frascheri L, Descartes F. Magnetic resonance imaging findings in substance abuse: alcohol and alcoholism and syndromes associated with alcohol abuse. Top Magn Reson Imaging 2005; 16:223-230
21. Arbelaez A, Pajon A, Castillo M. Acute Marchiafava-Bignami disease: MR findings in two patients. AJNR 2003; 24:1955-1957
22. Kim MJ, Kim JK, Yoo BG, Kim KS, Jo YD. Acute Marchiafava-Bignami Disease with widespread callosal and cortical lesions. J Korean Med Sci 2007; 22:908-911
23. Johkura K, Naito M, Naka T. Cortical involvement in Marchiafava-Bignami disease. AJNR 2005; 26:670-673
24. Friese SA, Bitzer M, Freudenstein D, Voigt K, Kuker W. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000; 42:795-802
25. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75[suppl 3]:iii22-iii28
26. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 1959; 81:154-172
27. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979; 102:361-385
28. Miller GM, Baker HL Jr, Okazaki H, Whisnant JP. Central pontine myelinolysis and its imitators: MR findings. Radiology 1988; 168:795-802
29. Yoon B, Shim YS, Chung SW. Central pontine and extrapontine myelinolysis after alcohol withdrawal. Alcohol Alcohol 2008; 43:647-649
30. Kumar S, Fowler M, Gonzalez-Toledo E, Jaffe SL. Central pontine myelinolysis, an update. Neurol Res 2006; 28:360-366
31. Osborn AG, Cooper JA, Castillo M, et al. Diagnostic imaging: brain. Salt Lake City, UT: Amirsys, 2004
32. Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR 2004; 25:210-213
33. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002; 47:3-10
34. Rippe DJ, Edwards MK, D'Amour PG, Holden RW, Roos KL. MR imaging of central pontine myelinolysis. J Comput Assist Tomogr 1987; 11:724-726
35. Thompson PD, Miller D, Gledhill RF, Rossor MN. Magnetic resonance imaging in central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1989; 52:675-677 (Pubitemid 19151733)
36. Chua GC, Sitoh YY, Lim CC, Chua HC, Ng PY. MR findings in osmotic myelinolysis. Clin Radiol 2002; 57:800-806
37. Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med 1999; 222:99-112
38. Sherlock S. Hepatic encephalopathy. Br J Hosp Med 1977; 17:144-146, 151-144, 159
39. Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem Int 2002; 41:271-277
40. Normandin L, Hazell AS. Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab Brain Dis 2002; 17:375-387
41. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002; 17:221-227
42. Rao KV, Norenberg MD. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 2001; 16:67-78
43. Rose C, Butterworth RF, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117:640-644
44. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification - final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35:716-721
45. Weissenborn K. Diagnosis of encephalopathy. Digestion 1998; 59[suppl 2]:22-24
46. Vymazal J, Babis M, Brooks RA, et al. T1 and T2 alterations in the brains of patients with hepatic cirrhosis. AJNR 1996; 17:333-336
47. Cordoba J, Raguer N, Flavia M, et al. T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities. Hepatology 2003; 38:1026-1033
48. Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR 2005; 26:347-351
49. Rovira A, Cordoba J, Sanpedro F, Grive E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002; 59:335-341
50. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:9-14
51. Minguez B, Rovira A, Alonso J, Cordoba J. Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR 2007; 28:1499-1500
52. Brunberg JA, Kanal E, Hirsch W, Van Thiel DH. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR 1991; 12:909-914
53. Morgan MY. Cerebral magnetic resonance imaging in patients with chronic liver disease. Metab Brain Dis 1998; 13:273-290
54. Dietemann JL, Reimund JM, Diniz RL, et al. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition. Neuroradiology 1998; 40:793-796
55. Lod i R. T. C., Stracciari, A. et at. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62:762-766
56. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43:698-706
57. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR 2006; 27:1019-1026
58. Ranjan P, Mishra AM, Kale R, et al. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005; 20:181-192
59. Häussinger D, Laubenberger J, vom Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107:1475-1480
60. Lee JH, Seo DW, Lee YS, et al. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999; 94:2206-2213
61. Laubenberger J, Häussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymp tomatic patients with liver cirrhosis. Gastroenterology 1997; 112:1610-1616
62. Geissler A, Lock G, Frund R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25:48-54
63. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193:457-463
64. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182:19-27
65. Kostler H. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 1998; 13:291-301
66. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4:469-480
67. Hughes JR. Alcohol withdrawal seizures. Epilepsy Behav 2009; 15:92-97
68. Kostler H. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 1998;13:291-301
69. Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry 1985; 48:628-634
70. Echevarria MG. On alcoholic epilepsy. J Ment Sci 1881; 26:489-519
71. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res 1996; 20:348-354
72. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR 2007; 189:904-912